ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 694

Serum Wisteria Floribunda Agglutinin-Positive Mac-2-Binding Protein Can Reflect Systemic Lupus Erythematosus Activity

Sung Soo Ahn1, Younhee Park2, Seung Min Jung1, Jason Jungsik Song1, Yong-Beom Park1 and Sang-Won Lee1, 1Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of (South), 2Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Biomarkers, Disease Activity, galectin and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Abstract Background/Purpose : Serum Mac-2-binding protein (M2BP) is elevated in various chronic inflammatory diseases. Recently, the Wisteria floribunda agglutinin positive-M2BP (WFA+-M2BP) immunoassay has shown promise in detection of highly glycosylated M2BP. We aimed to evaluate the clinical utility of serum M2BP for assessing disease activity of systemic lupus erythematosus (SLE), using the WFA+-M2BP immunoassay. Methods : Serum M2BP was measured in 203 patients with SLE. The associations between SLEDAI-2K and variables was assessed using multivariate linear regression analysis. The relationship between serum M2BP and laboratory variables related to the SLE disease activity index (SLEDAI)-2K and inflammatory burdens was evaluated by Pearson¡¯s correlation analysis. Multivariate logistic regression analysis was used to compare the odds ratios (ORs) of laboratory variables in predicting active SLE. Results : Eighty patients were classified as having active SLE (SLEDAI-2K ¡Ã 5) and 123 patients as having inactive SLE. The median serum M2BP was higher in patients with active SLE than those with inactive SLE (2.1 vs. 0.9, p < 0.001) (Table 1). In multivariate linear regression analysis, serum M2BP, anti-ds DNA, C3, and erythrocyte sedimentation rate were associated with SLEDAI-2K (Table 2). Serum M2BP was strongly correlated with laboratory variables related to SLEDAI-2K and inflammatory burdens, compared to other significant variables. Multivariate logistic regression analysis demonstrated that serum M2BP was more useful in predicting active SLE than other laboratory variables. Conclusion : Serum M2BP can reflect SLE activity and furthermore, it can predict active SLE. We suggest that serum M2BP may be a convenient complementary laboratory tool to SLEDAI-2K in the clinical setting.   References 1. Nielsen CT, et al. Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus. Lupus Sci Med 2014;1(1):e000026.  

 

 


Disclosure: S. S. Ahn, None; Y. Park, None; S. M. Jung, None; J. J. Song, None; Y. B. Park, None; S. W. Lee, None.

To cite this abstract in AMA style:

Ahn SS, Park Y, Jung SM, Song JJ, Park YB, Lee SW. Serum Wisteria Floribunda Agglutinin-Positive Mac-2-Binding Protein Can Reflect Systemic Lupus Erythematosus Activity [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/serum-wisteria-floribunda-agglutinin-positive-mac-2-binding-protein-can-reflect-systemic-lupus-erythematosus-activity/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/serum-wisteria-floribunda-agglutinin-positive-mac-2-binding-protein-can-reflect-systemic-lupus-erythematosus-activity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology